Axsome Therapeutics
Patents, Design & Utilities

Last updated:

List of all Axsome Therapeutics patents 180 in total

Status Patent
Application
Utility: REBOXETINE TO TREAT NARCOLEPSY External link
Filling date: 5 Sep 2025 Issue date: 8 Sep 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Dosage forms and methods for enantiomerically enriched or pure bupropion External link
Filling date: 5 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 30 Aug 2022
Application
Utility: DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION External link
Filling date: 5 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION External link
Filling date: 5 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION External link
Filling date: 5 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: USE OF ESREBOXETINE TO TREAT NERVOUS SYSTEM DISORDERS SUCH AS FIBROMYALGIA External link
Filling date: 5 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 14 Jul 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 28 Jun 2022
Application
Utility: METHODS OF MODULATING TETRABENAZINE METABOLITES PLASMA LEVELS USING BUPROPION External link
Filling date: 5 Sep 2025 Issue date: 23 Jun 2022
Grant
Utility: Use of reboxetine to treat narcolepsy External link
Filling date: 5 Sep 2025 Issue date: 21 Jun 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 14 Jun 2022
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 9 Jun 2022
Grant
Utility: Use of reboxetine to treat narcolepsy External link
Filling date: 5 Sep 2025 Issue date: 7 Jun 2022
Grant
Utility: Dosage forms and methods for enantiomerically enriched or pure bupropion External link
Filling date: 5 Sep 2025 Issue date: 31 May 2022
Grant
Utility: Dosage forms and methods for enantiomerically enriched or pure bupropion External link
Filling date: 5 Sep 2025 Issue date: 31 May 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 17 May 2022
Grant
Utility: Dosage forms and methods for enantiomerically enriched or pure bupropion External link
Filling date: 5 Sep 2025 Issue date: 17 May 2022
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 7 Apr 2022
Grant
Utility: Dosage forms and methods for enantiomerically enriched or pure bupropion External link
Filling date: 5 Sep 2025 Issue date: 5 Apr 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 29 Mar 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 29 Mar 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 29 Mar 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 8 Mar 2022
Application
Utility: METHODS OF MODULATING TETRABENAZINE METABOLITES PLASMA LEVELS USING BUPROPION External link
Filling date: 5 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 13 Jan 2022
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 11 Jan 2022
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 30 Dec 2021
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 28 Dec 2021
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 2 Dec 2021
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 2 Dec 2021
Application
Utility: USE OF REBOXETINE TO TREAT NARCOLEPSY External link
Filling date: 5 Sep 2025 Issue date: 2 Dec 2021
Grant
Utility: Use of reboxetine to treat narcolepsy External link
Filling date: 5 Sep 2025 Issue date: 30 Nov 2021
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 30 Nov 2021
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 25 Nov 2021
Grant
Utility: Dosage forms and methods for enantiomerically enriched or pure bupropion External link
Filling date: 5 Sep 2025 Issue date: 23 Nov 2021
Grant
Utility: Dosage forms and methods for enantiomerically enriched or pure bupropion External link
Filling date: 5 Sep 2025 Issue date: 23 Nov 2021
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION External link
Filling date: 5 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM External link
Filling date: 5 Sep 2025 Issue date: 21 Oct 2021
Grant
Utility: Use of reboxetine to treat narcolepsy External link
Filling date: 5 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: Pharmaceutical compositions comprising meloxicam External link
Filling date: 5 Sep 2025 Issue date: 5 Oct 2021

Showing 1 to 50 of 180 patents.